ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 194 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,125 | +184.9% | 548,782 | +445.6% | 0.03% | +188.9% |
| Q2 2023 | $2,150 | -99.9% | 100,581 | +135.9% | 0.01% | -10.0% |
| Q2 2022 | $2,016,000 | -60.5% | 42,640 | -40.6% | 0.01% | -52.4% |
| Q1 2022 | $5,102,000 | -48.4% | 71,773 | -45.8% | 0.02% | -43.2% |
| Q4 2021 | $9,896,000 | -26.9% | 132,527 | -44.5% | 0.04% | -28.8% |
| Q3 2021 | $13,536,000 | -16.2% | 238,640 | -35.0% | 0.05% | -14.8% |
| Q2 2021 | $16,155,000 | -29.4% | 367,012 | -20.9% | 0.06% | -31.5% |
| Q1 2021 | $22,871,000 | +16.2% | 463,774 | -0.8% | 0.09% | +17.1% |
| Q4 2020 | $19,684,000 | -8.3% | 467,514 | -0.3% | 0.08% | -15.6% |
| Q3 2020 | $21,474,000 | +3.5% | 469,115 | +13.5% | 0.09% | +1.1% |
| Q2 2020 | $20,757,000 | +17.4% | 413,385 | +20.2% | 0.09% | -11.9% |
| Q1 2020 | $17,687,000 | -16.9% | 343,882 | -0.2% | 0.10% | +4.1% |
| Q4 2019 | $21,282,000 | +4.2% | 344,450 | +1.3% | 0.10% | +11.5% |
| Q3 2019 | $20,426,000 | -40.3% | 339,939 | -16.1% | 0.09% | -47.0% |
| Q2 2019 | $34,196,000 | -8.3% | 405,269 | +3.8% | 0.16% | +1.9% |
| Q1 2019 | $37,297,000 | +51.7% | 390,476 | +12.5% | 0.16% | +32.0% |
| Q4 2018 | $24,583,000 | -35.6% | 347,004 | -22.3% | 0.12% | -22.8% |
| Q3 2018 | $38,170,000 | -13.7% | 446,675 | +17.0% | 0.16% | -17.3% |
| Q2 2018 | $44,242,000 | +147.0% | 381,729 | +72.4% | 0.19% | +148.1% |
| Q1 2018 | $17,912,000 | +1097.3% | 221,385 | +768.6% | 0.08% | +1183.3% |
| Q4 2017 | $1,496,000 | -81.5% | 25,489 | -90.3% | 0.01% | -83.8% |
| Q1 2017 | $8,071,000 | -57.6% | 262,073 | -53.9% | 0.04% | -60.2% |
| Q4 2016 | $19,049,000 | +93.8% | 568,686 | +54.0% | 0.09% | +89.8% |
| Q3 2016 | $9,828,000 | -35.4% | 369,297 | -46.5% | 0.05% | -37.2% |
| Q2 2016 | $15,218,000 | -35.9% | 690,136 | -14.6% | 0.08% | -35.0% |
| Q1 2016 | $23,729,000 | -11.2% | 807,874 | -0.2% | 0.12% | -14.3% |
| Q4 2015 | $26,728,000 | +0.5% | 809,422 | +10.0% | 0.14% | -3.4% |
| Q3 2015 | $26,588,000 | +121.1% | 735,635 | +175.2% | 0.14% | +150.0% |
| Q2 2015 | $12,025,000 | +13114.3% | 267,270 | +8911.1% | 0.06% | – |
| Q1 2015 | $91,000 | – | 2,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |